Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
Breast Cancer
Jun 17, 2024, 01:50 |
Blog
The fifth cohort of the CCB successfully concluded on June 15th - European School of Oncology
European School of Oncology (ESO) shared a post on LinkedIn: . “The fifth cohort of the…
Jun 16, 2024, 06:11 |
Societies
15 Posts Not To Miss From EACR2024!
The 2024 Annual Congress of the European Association for Cancer Research (EACR 2024) was a…
Jun 15, 2024, 16:02 |
Dialogues
Oncodaily Talks: Dialogue with Giuseppe Curigliano, hosted by Chandler Park
OncoDaily Talks gathers people worldwide to discuss challenges in cancer care. We share creative solutions…
Jun 15, 2024, 05:10 |
Blog
Shearwood McClelland III: Grateful to have won an Radiation Oncology Institute Grant
Shearwood McClelland III, Director of Spine Oncology, Department of Radiation Oncology at University Hospitals, made…
Jun 15, 2024, 04:35 |
Blog
Mitchell Elliott: Truly an honour to join this amazing group of NOYCIA award recipients this year
Mitchell Elliott, Medical Oncology Resident at the University of Toronto, shared a post by Novartis Canada on…
Jun 15, 2024, 03:45 |
Blog
Atlal Abusanad: My latest narrative in ASCO connection
Atlal Abusanad, Associate professor of medical oncology at King AbdulAziz University, shared on LinkedIn: "My latest…
Jun 15, 2024, 03:04 |
Blog
Douglas Flora: Thank you to all who sponsored and supported our inaugural event
Douglas Flora shared a post by Trish Boh, Executive Secretary to Executive Medical Director of…
Jun 14, 2024, 21:00 |
Blog
Michail Ignatiadis: Humble to have led this EBCC14 manifesto
Quoting Michail Ignatiadis, Director of Breast Medical Oncology Clinic and Program, Jules Bordet Institute, on…
Jun 14, 2024, 05:56 |
Blog
Fumiko Ladd Chino: Dr. Kekoa Taparra and team evaluated 364 Phase 2/3 trials in 4 top journals
Fumiko Ladd Chino shared on X/Twitter: "Dr. Kekoa Taparra and team evaluated 364 Phase 2/3 trials…
Jun 14, 2024, 05:01 |
Insight
Mark Doolan: Our NoeticInsight team with Illuminate Health kicked off a series of meetings at ASCO24
Mark Doolan, Senior Vice President and Managing Director at NoeticInsight, shared on LinkedIn: “What a…
142
143
144
145
146
All:
2167
Posts:
1431 - 1440
Immunotherapy vs Chemotherapy: Success Rates, Side Effects, Costs Compared
Small Bowel Cancer: Symptoms & Causes, Types, Diagnosis and Treatment
Mikkael A. Sekeres, Candidate for Secretary of ASH
Paolo Tarantino: Top 10 Breast Cancer abstracts from ESMO2024
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 2
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube